 | • レポートコード：20QY06-00877 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、インターフェロンアルファ-2aバイオシミラーのグローバル市場について種類別（長持ちタイプ、普通タイプ）、用途別（C型肝炎、B型肝炎、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・インターフェロンアルファ-2aバイオシミラー市場の概要 ・世界の主要地域別インターフェロンアルファ-2aバイオシミラー市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のインターフェロンアルファ-2aバイオシミラー市場規模2015-2026：種類別（長持ちタイプ、普通タイプ） ・世界のインターフェロンアルファ-2aバイオシミラー市場規模2015-2026：用途別（C型肝炎、B型肝炎、その他） ・インターフェロンアルファ-2aバイオシミラーの北米市場規模2015-2020 ・インターフェロンアルファ-2aバイオシミラーのヨーロッパ市場規模2015-2020 ・インターフェロンアルファ-2aバイオシミラーの中国市場規模2015-2020 ・インターフェロンアルファ-2aバイオシミラーの日本市場規模2015-2020 ・インターフェロンアルファ-2aバイオシミラーの東南アジア市場規模2015-2020 ・インターフェロンアルファ-2aバイオシミラーのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Biosidus、Zydus Cadila、Nanogen、Amega Biotech、Rhein Minapharm Biogenetics、PROBIOMED、3sbio） ・インターフェロンアルファ-2aバイオシミラーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インターフェロンアルファ-2aバイオシミラーの市場動向・機会・課題 ・調査の結論 |
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
The global average price of Interferon Alpha-2a Biosimilar is in the decreasing trend, from 186.78 USD/Unit in 2013 to 64.67 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Interferon Alpha-2a Biosimilar includes ordinary type and long-lasting type, and the proportion of ordinary type in 2017 is about 64%, and the proportion is in increasing trend from 2013 to 2017.
Interferon Alpha-2a Biosimilar is widely used for hepatitis C, hepatitis B and other diseases. The most proportion of Interferon Alpha-2a Biosimilar is used for hepatitis C, and the proportion in 2017 is 46%.
Europe is the largest supplier of Interferon Alpha-2a Biosimilar, with a production market share nearly 70% in 2017.
South America is the largest consumption place, with a consumption market share nearly 26% in 2017. Following South America, Europe is the second largest consumption place with the consumption market share of 22%.
Market competition is not intense. Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Interferon Alpha-2a Biosimilar Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Interferon Alpha-2a Biosimilar market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Interferon Alpha-2a Biosimilar industry.
Based on our recent survey, we have several different scenarios about the Interferon Alpha-2a Biosimilar YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 307.4 million in 2019. The market size of Interferon Alpha-2a Biosimilar will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Interferon Alpha-2a Biosimilar Scope and Market Size
The global Interferon Alpha-2a Biosimilar market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interferon Alpha-2a Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Interferon Alpha-2a Biosimilar market is segmented into
Long-lasting Type
Ordinary Type
Segment by Application, the Interferon Alpha-2a Biosimilar market is segmented into
Hepatitis C
Hepatitis B
Other
The Interferon Alpha-2a Biosimilar market is analysed and market size information is provided by regions (countries). Segment by Application, the Interferon Alpha-2a Biosimilar market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Interferon Alpha-2a Biosimilar Market Share Analysis
Interferon Alpha-2a Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Interferon Alpha-2a Biosimilar business, the date to enter into the Interferon Alpha-2a Biosimilar market, Interferon Alpha-2a Biosimilar product introduction, recent developments, etc.
The major vendors covered:
Roche
Biosidus
Zydus Cadila
Nanogen
Amega Biotech
Rhein Minapharm Biogenetics
PROBIOMED
3sbio
1 Interferon Alpha-2a Biosimilar Market Overview
1.1 Interferon Alpha-2a Biosimilar Product Scope
1.2 Interferon Alpha-2a Biosimilar Segment by Type
1.2.1 Global Interferon Alpha-2a Biosimilar Sales by Type (2020-2026)
1.2.2 Long-lasting Type
1.2.3 Ordinary Type
1.3 Interferon Alpha-2a Biosimilar Segment by Application
1.3.1 Global Interferon Alpha-2a Biosimilar Sales Comparison by Application (2020-2026)
1.3.2 Hepatitis C
1.3.3 Hepatitis B
1.3.4 Other
1.4 Interferon Alpha-2a Biosimilar Market Estimates and Forecasts (2015-2026)
1.4.1 Global Interferon Alpha-2a Biosimilar Sales Growth Rate (2015-2026)
1.4.2 Global Interferon Alpha-2a Biosimilar Revenue and Growth Rate (2015-2026)
1.4.3 Global Interferon Alpha-2a Biosimilar Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Interferon Alpha-2a Biosimilar Industry Impact
1.5.1 How the Covid-19 is Affecting the Interferon Alpha-2a Biosimilar Industry
1.5.1.1 Interferon Alpha-2a Biosimilar Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Interferon Alpha-2a Biosimilar Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Interferon Alpha-2a Biosimilar Players to Combat Covid-19 Impact
2 Interferon Alpha-2a Biosimilar Estimate and Forecast by Region
2.1 Global Interferon Alpha-2a Biosimilar Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Interferon Alpha-2a Biosimilar Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Interferon Alpha-2a Biosimilar Sales Market Share by Region (2015-2020)
2.2.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Region (2015-2020)
2.3 Global Interferon Alpha-2a Biosimilar Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Interferon Alpha-2a Biosimilar Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Interferon Alpha-2a Biosimilar Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Interferon Alpha-2a Biosimilar Estimates and Projections (2015-2026)
2.4.2 Europe Interferon Alpha-2a Biosimilar Estimates and Projections (2015-2026)
2.4.3 China Interferon Alpha-2a Biosimilar Estimates and Projections (2015-2026)
2.4.4 Japan Interferon Alpha-2a Biosimilar Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Interferon Alpha-2a Biosimilar Estimates and Projections (2015-2026)
2.4.6 India Interferon Alpha-2a Biosimilar Estimates and Projections (2015-2026)
3 Global Interferon Alpha-2a Biosimilar Competition Landscape by Players
3.1 Global Top Interferon Alpha-2a Biosimilar Players by Sales (2015-2020)
3.2 Global Top Interferon Alpha-2a Biosimilar Players by Revenue (2015-2020)
3.3 Global Interferon Alpha-2a Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon Alpha-2a Biosimilar as of 2019)
3.4 Global Interferon Alpha-2a Biosimilar Average Price by Company (2015-2020)
3.5 Manufacturers Interferon Alpha-2a Biosimilar Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Interferon Alpha-2a Biosimilar Players (Opinion Leaders)
4 Global Interferon Alpha-2a Biosimilar Market Size by Type
4.1 Global Interferon Alpha-2a Biosimilar Historic Market Review by Type (2015-2020)
4.1.1 Global Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
4.1.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Type (2015-2020)
4.1.3 Global Interferon Alpha-2a Biosimilar Price by Type (2014-2020)
4.2 Global Interferon Alpha-2a Biosimilar Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Interferon Alpha-2a Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Interferon Alpha-2a Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Global Interferon Alpha-2a Biosimilar Price Forecast by Type (2021-2026)
5 Global Interferon Alpha-2a Biosimilar Market Size by Application
5.1 Global Interferon Alpha-2a Biosimilar Historic Market Review by Application (2015-2020)
5.1.1 Global Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
5.1.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Application (2015-2020)
5.1.3 Global Interferon Alpha-2a Biosimilar Price by Application (2015-2020)
5.2 Global Interferon Alpha-2a Biosimilar Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Interferon Alpha-2a Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Interferon Alpha-2a Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Interferon Alpha-2a Biosimilar Price Forecast by Application (2021-2026)
3 North America Interferon Alpha-2a Biosimilar Market Facts & Figures
3.2 North America Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
3.3 North America Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
3.4 North America Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
4 Europe Interferon Alpha-2a Biosimilar Market Facts & Figures
4.2 Europe Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
4.3 Europe Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
4.4 Europe Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
5 China Interferon Alpha-2a Biosimilar Market Facts & Figures
5.2 China Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
5.3 China Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
5.4 China Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
6 Japan Interferon Alpha-2a Biosimilar Market Facts & Figures
6.2 Japan Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
6.3 Japan Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
6.4 Japan Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
7 Southeast Asia Interferon Alpha-2a Biosimilar Market Facts & Figures
7.2 Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
8 India Interferon Alpha-2a Biosimilar Market Facts & Figures
8.2 India Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
8.3 India Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
8.4 India Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Interferon Alpha-2a Biosimilar Business
12.1 Roche
12.1.1 Roche Interferon Alpha-2a Biosimilar Corporation Information
12.1.2 Roche Interferon Alpha-2a Biosimilar Business Overview and Total Revenue
12.1.3 Roche Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Interferon Alpha-2a Biosimilar Products Offered
12.1.5 Roche Recent Development
12.2 Biosidus
12.2.1 Biosidus Interferon Alpha-2a Biosimilar Corporation Information
12.2.2 Biosidus Interferon Alpha-2a Biosimilar Business Overview and Total Revenue
12.2.3 Biosidus Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biosidus Interferon Alpha-2a Biosimilar Products Offered
12.2.5 Biosidus Recent Development
12.3 Zydus Cadila
12.3.1 Zydus Cadila Interferon Alpha-2a Biosimilar Corporation Information
12.3.2 Zydus Cadila Interferon Alpha-2a Biosimilar Business Overview and Total Revenue
12.3.3 Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Zydus Cadila Interferon Alpha-2a Biosimilar Products Offered
12.3.5 Zydus Cadila Recent Development
12.4 Nanogen
12.4.1 Nanogen Interferon Alpha-2a Biosimilar Corporation Information
12.4.2 Nanogen Interferon Alpha-2a Biosimilar Business Overview and Total Revenue
12.4.3 Nanogen Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Nanogen Interferon Alpha-2a Biosimilar Products Offered
12.4.5 Nanogen Recent Development
12.5 Amega Biotech
12.5.1 Amega Biotech Interferon Alpha-2a Biosimilar Corporation Information
12.5.2 Amega Biotech Interferon Alpha-2a Biosimilar Business Overview and Total Revenue
12.5.3 Amega Biotech Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amega Biotech Interferon Alpha-2a Biosimilar Products Offered
12.5.5 Amega Biotech Recent Development
12.6 Rhein Minapharm Biogenetics
12.6.1 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Corporation Information
12.6.2 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Business Overview and Total Revenue
12.6.3 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Products Offered
12.6.5 Rhein Minapharm Biogenetics Recent Development
12.7 PROBIOMED
12.7.1 PROBIOMED Interferon Alpha-2a Biosimilar Corporation Information
12.7.2 PROBIOMED Interferon Alpha-2a Biosimilar Business Overview and Total Revenue
12.7.3 PROBIOMED Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.7.4 PROBIOMED Interferon Alpha-2a Biosimilar Products Offered
12.7.5 PROBIOMED Recent Development
12.8 3sbio
12.8.1 3sbio Interferon Alpha-2a Biosimilar Corporation Information
12.8.2 3sbio Interferon Alpha-2a Biosimilar Business Overview and Total Revenue
12.8.3 3sbio Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.8.4 3sbio Interferon Alpha-2a Biosimilar Products Offered
12.8.5 3sbio Recent Development
13 Interferon Alpha-2a Biosimilar Manufacturing Cost Analysis
13.1 Interferon Alpha-2a Biosimilar Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Interferon Alpha-2a Biosimilar
13.4 Interferon Alpha-2a Biosimilar Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Interferon Alpha-2a Biosimilar Distributors List
14.3 Interferon Alpha-2a Biosimilar Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Interferon Alpha-2a Biosimilar Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Interferon Alpha-2a Biosimilar Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Interferon Alpha-2a Biosimilar Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Interferon Alpha-2a Biosimilar Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Interferon Alpha-2a Biosimilar Players to Combat Covid-19 Impact
Table 8. Global Market Interferon Alpha-2a Biosimilar Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Interferon Alpha-2a Biosimilar Sales (MT) by Region (2015-2020)
Table 10. Global Interferon Alpha-2a Biosimilar Sales Market Share by Region (2015-2020)
Table 11. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Interferon Alpha-2a Biosimilar Revenue Share by Region (2015-2020)
Table 13. Global Interferon Alpha-2a Biosimilar Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Interferon Alpha-2a Biosimilar Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Interferon Alpha-2a Biosimilar Revenue Share Forecast by Region (2021-2026)
Table 17. Global Interferon Alpha-2a Biosimilar (MT) of Key Companies (2015-2020)
Table 18. Global Interferon Alpha-2a Biosimilar Sales Share by Company (2015-2020)
Table 19. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Interferon Alpha-2a Biosimilar Revenue Share by Company (2015-2020)
Table 21. Global Interferon Alpha-2a Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon Alpha-2a Biosimilar as of 2019)
Table 22. Global Interferon Alpha-2a Biosimilar Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Interferon Alpha-2a Biosimilar Manufacturing Sites and Area Served
Table 24. Manufacturers Interferon Alpha-2a Biosimilar Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Interferon Alpha-2a Biosimilar Players
Table 27. Global Interferon Alpha-2a Biosimilar Sales (MT) by Type (2015-2020)
Table 28. Global Interferon Alpha-2a Biosimilar Sales Share by Type (2015-2020)
Table 29. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Interferon Alpha-2a Biosimilar Price (MT) by Type (2015-2020)
Table 31. Global Interferon Alpha-2a Biosimilar Sales Share by Type (2021-2026)
Table 32. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Interferon Alpha-2a Biosimilar Revenue Share by Type (2021-2026)
Table 34. Global Interferon Alpha-2a Biosimilar Price (MT) by Type (2021-2026)
Table 35. Global Interferon Alpha-2a Biosimilar Sales (MT) by Application (2015-2020)
Table 36. Global Interferon Alpha-2a Biosimilar Sales Share by Application (2015-2020)
Table 37. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Interferon Alpha-2a Biosimilar Price (MT) by Application (2015-2020)
Table 39. Global Interferon Alpha-2a Biosimilar Sales (MT) by Application (2021-2026)
Table 40. Global Interferon Alpha-2a Biosimilar Sales Share by Application (2021-2026)
Table 41. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Interferon Alpha-2a Biosimilar Revenue Share by Application (2021-2026)
Table 43. Global Interferon Alpha-2a Biosimilar Price (MT) by Application (2021-2026)
Table 44. United States Interferon Alpha-2a Biosimilar Sales (MT) by Company (2015-2020)
Table 45. United States Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
Table 46. United States Interferon Alpha-2a Biosimilar Sales (MT) by Type (2015-2020)
Table 47. United States Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
Table 48. United States Interferon Alpha-2a Biosimilar Sales (MT) by Application (2015-2020)
Table 49. United States Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
Table 50. Europe Interferon Alpha-2a Biosimilar Sales (MT) by Company (2015-2020)
Table 51. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
Table 52. Europe Interferon Alpha-2a Biosimilar Sales (MT) by Type (2015-2020)
Table 53. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
Table 54. Europe Interferon Alpha-2a Biosimilar Sales (MT) by Application (2015-2020)
Table 55. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
Table 56. China Interferon Alpha-2a Biosimilar Sales (MT) by Company (2015-2020)
Table 57. China Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
Table 58. China Interferon Alpha-2a Biosimilar Sales (MT) by Type (2015-2020)
Table 59. China Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
Table 60. China Interferon Alpha-2a Biosimilar Sales (MT) by Application (2015-2020)
Table 61. China Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
Table 62. Japan Interferon Alpha-2a Biosimilar Sales (MT) by Company (2015-2020)
Table 63. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
Table 64. Japan Interferon Alpha-2a Biosimilar Sales (MT) by Type (2015-2020)
Table 65. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
Table 66. Japan Interferon Alpha-2a Biosimilar Sales (MT) by Application (2015-2020)
Table 67. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Interferon Alpha-2a Biosimilar Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Interferon Alpha-2a Biosimilar Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Interferon Alpha-2a Biosimilar Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
Table 74. India Interferon Alpha-2a Biosimilar Sales (MT) by Company (2015-2020)
Table 75. India Interferon Alpha-2a Biosimilar Sales Market Share by Company (2015-2020)
Table 76. India Interferon Alpha-2a Biosimilar Sales (MT) by Type (2015-2020)
Table 77. India Interferon Alpha-2a Biosimilar Sales Market Share by Type (2015-2020)
Table 78. India Interferon Alpha-2a Biosimilar Sales (MT) by Application (2015-2020)
Table 79. India Interferon Alpha-2a Biosimilar Sales Market Share by Application (2015-2020)
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Roche Interferon Alpha-2a Biosimilar Product
Table 84. Roche Recent Development
Table 85. Biosidus Corporation Information
Table 86. Biosidus Description and Business Overview
Table 87. Biosidus Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Biosidus Interferon Alpha-2a Biosimilar Product
Table 89. Biosidus Recent Development
Table 90. Zydus Cadila Corporation Information
Table 91. Zydus Cadila Description and Business Overview
Table 92. Zydus Cadila Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Zydus Cadila Interferon Alpha-2a Biosimilar Product
Table 94. Zydus Cadila Recent Development
Table 95. Nanogen Corporation Information
Table 96. Nanogen Description and Business Overview
Table 97. Nanogen Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Nanogen Interferon Alpha-2a Biosimilar Product
Table 99. Nanogen Recent Development
Table 100. Amega Biotech Corporation Information
Table 101. Amega Biotech Description and Business Overview
Table 102. Amega Biotech Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Amega Biotech Interferon Alpha-2a Biosimilar Product
Table 104. Amega Biotech Recent Development
Table 105. Rhein Minapharm Biogenetics Corporation Information
Table 106. Rhein Minapharm Biogenetics Description and Business Overview
Table 107. Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Product
Table 109. Rhein Minapharm Biogenetics Recent Development
Table 110. PROBIOMED Corporation Information
Table 111. PROBIOMED Description and Business Overview
Table 112. PROBIOMED Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. PROBIOMED Interferon Alpha-2a Biosimilar Product
Table 114. PROBIOMED Recent Development
Table . 3sbio Corporation Information
Table . 3sbio Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . 3sbio Description and Business Overview
Table . 3sbio Interferon Alpha-2a Biosimilar Product
Table . 3sbio Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Interferon Alpha-2a Biosimilar Distributors List
Table 123. Interferon Alpha-2a Biosimilar Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Interferon Alpha-2a Biosimilar Product Picture
Figure 2. Global Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Interferon Alpha-2a Biosimilar Market Share by Application in 2020 & 2026
Figure 6. Hepatitis C Examples
Figure 7. Hepatitis B Examples
Figure 8. Other Examples
Figure 9. Global Interferon Alpha-2a Biosimilar Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Interferon Alpha-2a Biosimilar Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Interferon Alpha-2a Biosimilar Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Interferon Alpha-2a Biosimilar Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Interferon Alpha-2a Biosimilar Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Interferon Alpha-2a Biosimilar Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Interferon Alpha-2a Biosimilar Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Interferon Alpha-2a Biosimilar Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Interferon Alpha-2a Biosimilar Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Interferon Alpha-2a Biosimilar Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Interferon Alpha-2a Biosimilar Players Market Share by Revenue in Interferon Alpha-2a Biosimilar 2015 & 2019
Figure 27. Interferon Alpha-2a Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Interferon Alpha-2a Biosimilar Revenue Share by Type (2015-2020)
Figure 29. Global Interferon Alpha-2a Biosimilar Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Interferon Alpha-2a Biosimilar Revenue Share by Application (2015-2020)
Figure 31. Global Interferon Alpha-2a Biosimilar Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2019
Figure 33. United States Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2019
Figure 34. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Company in 2019
Figure 35. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2019
Figure 36. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2019
Figure 37. China Interferon Alpha-2a Biosimilar Sales Market Share by Company in 2019
Figure 38. China Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2019
Figure 39. China Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2019
Figure 40. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Company in 2019
Figure 41. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2019
Figure 42. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2019
Figure 43. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Company in 2019
Figure 44. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2019
Figure 45. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2019
Figure 46. India Interferon Alpha-2a Biosimilar Sales Market Share by Company in 2019
Figure 47. India Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2019
Figure 48. India Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2019
Figure 49. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Biosidus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Nanogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Amega Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Rhein Minapharm Biogenetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. PROBIOMED Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. 3sbio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Interferon Alpha-2a Biosimilar
Figure 59. Manufacturing Process Analysis of Interferon Alpha-2a Biosimilar
Figure 60. Interferon Alpha-2a Biosimilar Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
インフリキシマブ・バイオシミラーの世界市場レポート2020 Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases. Market Analysis and Insights: Global Infliximab and biosimilar Market The global Infliximab and biosimilar m…- バイオシミラーインスリンの世界市場レポート2020 Market Analysis and Insights: Global Biosimilar Insulin Market The global Biosimilar Insulin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Biosimilar Insulin Scope and Market Size The global Biosimilar …
- バイオシミラー薬物の世界市場レポート2020 A recently published report by QY Research titled Global Biosimilar Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- インターフェロンの世界市場レポート2020 Interferons (IFNs) are a group of signaling proteins made and released by host cells in response to the presence of several pathogens, such as viruses, bacteria, parasites, and also tumor cells. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten th…
- バイオシミラーインスリンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Biosimilar Insulin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biosimilar Insulin market …